Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 3 Macroscopic/histologic findings (top) and scintigraphic images using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) (middle) or 99mTc-methylene diphosphonate (99mTc-MDP) (bottom) as the tracer in a group A patient with transthyretin amyloidosis who underwent combined heart-liver transplantation (left) and a group B patient with monoclonal immunoglobulin light-chain (AL) amyloidosis (right). Two paradoxes are apparent: 1) despite similar left ventricular (LV) thickness and amount of amyloidotic infiltration in the two patients, myocardial 99mTc-DPD uptake is characteristically strong (without bone uptake) in the patient with TTR-related amyloidosis and absent in the patient with AL amyloidosis (who had only bone uptake); 2) conversely, use of a different tracer (99mTc-MDP) results in absence of visually detectable myocardial uptake (accompanied by normal bone uptake) in both patients. The macrohistologic sections show pale gray-blue amyloid infiltrations at Azan Mallory trichrome staining, whereas Congo-red staining (lower insets) shows typical green birefringence under cross-polarized light microscopy. In the patient with TTR, immunohistochemical staining against TTR is positive (upper inset). RV = right ventricle.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement